Atlas Trials

Oral Supplementation of Gangliosides to Treat a Rare Metabolic Disorder

Clinical trial NCT02234024 · UNKNOWN

Trial details

NCT number
NCT02234024
Sponsor
DDC Clinic - Center for Special Needs Children
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
GM3 Synthase Deficiency
Start date
2014-01-01
Primary completion
2020-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.